Cite
Health economic evaluation of stent or endoluminal brachytherapy as a palliative strategy in patients with incurable cancer of the oesophagus or gastro-oesophageal junction: results of a randomized clinical trial.
MLA
Wenger U, et al. “Health Economic Evaluation of Stent or Endoluminal Brachytherapy as a Palliative Strategy in Patients with Incurable Cancer of the Oesophagus or Gastro-Oesophageal Junction: Results of a Randomized Clinical Trial.” European Journal of Gastroenterology & Hepatology, vol. 17, no. 12, Dec. 2005, pp. 1369–77. EBSCOhost, https://doi.org/10.1097/00042737-200512000-00017.
APA
Wenger U, Johnsson E, Bergquist H, Nyman J, Ejnell H, Lagergren J, Ruth M, Lundell L, Wenger, U., Johnsson, E., Bergquist, H., Nyman, J., Ejnell, H., Lagergren, J., Ruth, M., & Lundell, L. (2005). Health economic evaluation of stent or endoluminal brachytherapy as a palliative strategy in patients with incurable cancer of the oesophagus or gastro-oesophageal junction: results of a randomized clinical trial. European Journal of Gastroenterology & Hepatology, 17(12), 1369–1377. https://doi.org/10.1097/00042737-200512000-00017
Chicago
Wenger U, Johnsson E, Bergquist H, Nyman J, Ejnell H, Lagergren J, Ruth M, et al. 2005. “Health Economic Evaluation of Stent or Endoluminal Brachytherapy as a Palliative Strategy in Patients with Incurable Cancer of the Oesophagus or Gastro-Oesophageal Junction: Results of a Randomized Clinical Trial.” European Journal of Gastroenterology & Hepatology 17 (12): 1369–77. doi:10.1097/00042737-200512000-00017.